The discovery of SOD1 mutations in fALS patients (Rosen et al. 1993) led to the generation of the first transgenic ALS mouse model expressing SOD1G93A (Gurney et al. 1994). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.